Login
← Go Back
Windlas Biotech
WINDLAS · Pharma > Pharmaceuticals & Drugs · Chairman: Vivek Dhariwal · MD: Hitesh Windlass · Listing date: Aug. 17, 2021 · Employees: 1028 · Gurugram · http://windlasbiotech.com
Stock Price vs Company Growth
1d
3.4%
1w
9.6%
1m
2.5%
3m
14.9%
6m
50.1%
1y
111.0%
all
29.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 925 3.4%
800
1,197
Company Overview
Sales
696 Cr
Growth: 19.2%
Profit after Tax
61.2 Cr
Growth: 2.7%
Small Cap
1,934 Cr
P/E: 31.6x
Industry P/E: 35.6x
Fundamentals
Sales (Cr) ₹ 696
Growth 19.2%
EBITDA 12.4%
P/S 2.8x
Dividend 1.0%
P/E 31.6x
Book Value ₹ 229
PEG Ratio 1.6x
ROE 13.3%
P/B 4.0x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world. Awards, accreditations and recognitions2018: The company was awarded the TV100 Industrial Excellence Award in the field of medicine.
Belongs to (4 Indices)
Investors (2)
samrocks...
jainam.b...